More NewsSequenom Appoints Paul Maier as Interim CFO

Sequenom Appoints Paul Maier as Interim CFO

Sequenom, a life sciences company, has appointed Paul V. Maier as interim chief financial officer (CFO), reporting directly to the company’s interim chief executive officer (CEO) and chairman of the board, Harry Hixson, Jr.

Maier has been an independent financial consultant since February 2007. He served as senior vice president and CFO of Ligand Pharmaceuticals from 1992 until January 2007, where he helped build Ligand from a venture stage boutique company to a commercial, integrated biopharmaceutical organisation. During his tenure at Ligand, Maier helped to raise over US$1bn in equity and debt financings. Prior to Ligand, Maier spent six years in various management and finance positions at ICN Pharmaceuticals.

Related Articles

Preparing for GDPR? Here’s four things to consider

More News Preparing for GDPR? Here’s four things to consider

2m Elliott Wiseman
Cash flow in focus for investors

Cash Management Cash flow in focus for investors

3m Conor Deegan
Treasury TV: Karen Pugsley, Domino's Pizza Group

More News Treasury TV: Karen Pugsley, Domino's Pizza Group

3m Victoria Beckett
Treasury TV: Yeng Butler compares US and European MMF reforms

Compliance Treasury TV: Yeng Butler compares US and European MMF reforms

3m Victoria Beckett
Treasury TV: Tim de Knegt, The Port of Rotterdam

10 Minutes With The Treasury Treasury TV: Tim de Knegt, The Port of Rotterdam

4m Victoria Beckett
Banks are selling clients short with short dated cash deposit U-turns

Banking Banks are selling clients short with short dated cash deposit U-turns

4m Victoria Beckett
What does sterling’s Brexit boost mean for UK manufacturers?

More News What does sterling’s Brexit boost mean for UK manufacturers?

4m Tasja Botha
FX for corporates: 5 best practices for treasurers

Economy FX for corporates: 5 best practices for treasurers

4m Mateo Graziosi